Sarepta Therapeutics, Inc. Vs. Gitlab, Inc. Industry Stock Comparison

Sell

42

SRPT
Sarepta Therapeutics, Inc.

Last Price:

$21.03

Seasonality Move:

10.38%

Sell

23

GTLB
Gitlab, Inc.

Last Price:

$37.99

Seasonality Move:

-19.14%

Sell

42

Sarepta Therapeutics, Inc. (SRPT) is a Sell

Is Sarepta Therapeutics, Inc. a Buy, Sell or Hold?

The current Sarepta Therapeutics, Inc. [SRPT] share price is $21.04. The Score for SRPT is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

Sell

23

Gitlab, Inc. (GTLB) is a Sell

Is Gitlab, Inc. a Buy, Sell or Hold?

The current Gitlab, Inc. [GTLB] share price is $38.00. The Score for GTLB is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
GTLB is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SRPT Stock Price Chart

What is Sarepta Therapeutics, Inc.'s stock price today?

The Sarepta Therapeutics, Inc. share price today is $21.04

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing slight buying pressure.

GTLB Stock Price Chart

What is Gitlab, Inc.'s stock price today?

The Gitlab, Inc. share price today is $38.00

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GTLB is experiencing slight selling pressure.

SRPT Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	3.92	Buy
Relative Strength Index (14 RSI):	51.11	Buy
Chaikin Money Flow:	1527880	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(18.4 - 22.24)	Buy
Bollinger Bands (100):	(17.55 - 22.19)	Buy

GTLB Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-1.59	Sell
Relative Strength Index (14 RSI):	37.81	Sell
Chaikin Money Flow:	-469172	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(38.22 - 42.54)	Sell
Bollinger Bands (100):	(41.16 - 48.38)	Sell

SRPT Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	21.48	Sell
20-day SMA:	21.06	Sell
50-day SMA:	20.78	Buy
200-day SMA:	32.06	Sell
8-day EMA:	11.03	Buy
20-day EMA:	5.4	Buy
50-day EMA:	2.36	Buy
200-day EMA:	0.62	Buy

GTLB Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	38.92	Sell
20-day SMA:	39.62	Sell
50-day SMA:	43.61	Sell
200-day SMA:	45.7	Sell
8-day EMA:	38.57	Sell
20-day EMA:	39.91	Sell
50-day EMA:	42.43	Sell
200-day EMA:	46.7	Sell

Sarepta Therapeutics, Inc. Earnings Growth & SRPT Earnings Dates

Analysts estimate an earnings decrease this quarter of $1.60 per share, a decrease next quarter of $0.00 per share, a decrease this year of $6.03 per share, and an increase next year of $4.91 per share.

Gitlab, Inc. Earnings Growth & GTLB Earnings Dates

Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.50 per share, and an increase next year of $0.26 per share.

Sarepta Therapeutics, Inc. Technical Analysis

	Dec 8	Dec 9	Dec 10	Dec 11	Dec 12	Dec 15	Dec 16	Dec 17	Dec 18	Dec 19
	Dec
	08	09	10	11	12	15	16	17	18	19
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Gitlab, Inc. Technical Analysis

	Dec 8	Dec 9	Dec 10	Dec 11	Dec 12	Dec 15	Dec 16	Dec 17	Dec 18	Dec 19
	Dec
	08	09	10	11	12	15	16	17	18	19
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):